IP Library Granted Patent US 7,410,789
Granted Patent B2
US 7,410,789 · App. 11/366,315 · Granted Aug 12, 2008

Process for the fermentative production of S-adenosylmethionine

Assignee: Wacker Chemie AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,410,789
App. No.
11/366,315
Granted
Aug 12, 2008
Kind
B2
Abstract

A microorganism strain secreting S-adenosylmethionine having increased activity of the cmr (mdfA) gene product is provided.

Claims (6)

1. An isolated E. coli cell which secrets S-adenosylmethionine as a result of a modification in said cell to increase the activity of the poypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide of SEQ ID NO: 2 in the corresponding E. coli cell prior to modification, wherein said increase in ativity is due to over-expression of a nucleic acid encoding the polypeptide of SEQ ID NO: 2 by placing said nucleic acid under the control of a strong heterologous promoter.

2. The isolated E. coli cell of claim 1 wherein said E. coli cell exhibits at least 2 fold increased activity of the polypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide SEQ ID NO: 2 in the corresponding E. coli cell prior to modification.

3. The isolated E. coli cell of claim 1 wherein said E. coli cell exhibits at least 5 fold increased activity of the polypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide of SEQ ID NO: 2 in the corresponding E. coli cell prior to modification.

4. An isolated E. coli cell which secrets 5-adenosylmethionine as a result of a modification in said cell to increase the activity of the polypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide of SEQ ID NO: 2 in the corresponding E. coli cell prior to modification, wherein said increase in activity is due to an increase in the copy number of a nucleic acid encoding the polypeptide of SEQ ID NO: 2.

5. The isolated E. coli cell of claim 4 wherein said E. coli cell exhibits at least 5 fold increased activity of the polypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide of SEQ ID NO: 2 in the corresponding E. coli cell prior to modification.

6. The isolated E. coli cell of claim 4 wherein E. coli cell exhibits at least 5 fold increased activity of the polypeptide of SEQ ID NO: 2 compared to the activity of the polypeptide of SEQ ID NO: 2 in the corresponding E.coli cell prior to modification.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 21, 2007
From: CONSORTIUM FUR ELEKTROCHEMISHE INDUSTRIE GMBH
To: WACKER CHEMIE AG
Reel/Frame 019728/0028 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2006
From: SCHLOESSER, THOMAS; LEONHARTSBERGER, SUSANNE; FLINSPACH, RENATE
To: WACKER CHEMIE AG
Reel/Frame 017789/0785 →
Continuity (1)
Related Publication 20060211095A1 · Sep 21, 2006